Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 51.30
0.00 (0.00%)
At close: Dec 31, 2025
Sagittarius Life Science Market Cap
Sagittarius Life Science has a market cap or net worth of 3.47 billion as of December 31, 2025. Its market cap has increased by 206.83% in one year.
Market Cap
3.47B
Enterprise Value
2.65B
Revenue
424.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
51.30
Market Cap Chart
Since May 2, 2006, Sagittarius Life Science's market cap has increased from 288.69M to 3.47B, an increase of 1,100.29%. That is a compound annual growth rate of 13.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.47B | 233.24% |
| Dec 31, 2024 | 1.04B | -38.79% |
| Dec 29, 2023 | 1.70B | 28.26% |
| Dec 30, 2022 | 1.32B | 48.00% |
| Dec 30, 2021 | 895.00M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.42B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 31.06B |